Drug
Polyethylene Glycol
Polyethylene Glycol: highest development phase Post-Market, developed by Bausch Health. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Bausch Health
Trials
| Drug | Phase | Indication |
|---|---|---|
| Polyethylene glycol NCT01427296 | Post-Market | Colon Cleansing |
Latest
No recent events.
Follow Polyethylene Glycol on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.